Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trospium Chloride XR in Obese Female Patients With Overactive Bladder

NCT00932022 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00932022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00932022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trospium Chloride XR in Obese Female Patients With Overactive Bladder
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
December 31, 2011
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

incontinence, obesity, overactive bladder